$13.320
-0.482 (-3.62%)At close
AVAH News
AVAH Events
RBC Capital Prices Deal Within $11.65-$11.90 Range
The deal priced inside the $11.65-$11.90 target range. RBC Capital is acting as sole book running manager for the offering.
US Treasury Yields Rise, Dow Drops Over 700 Points
The sugar high of US Treasury's "put" to stem the rapid rise in longer-dated yields on Wednesday has worn off, sending those maturities higher and indices sharply lower across the board. Dow Industrials shed over 700 points, S&P 500 and Nasdaq Composite ended the day near their lows, while small-cap Russell 2000 index fell back below 3,000 for the first time in two weeks. There were few places to hide even in the more defensive areas of the market, with Consumer Staples dragged down by the 9% post-earnings retreat in shares of Walmartand the recently outperforming Healthcare giving back some of those gains. Tech was also mixed as strength in memory stocks was offset by selling in Infrastructure Software.In the opening hour of the evening session, panic is dialed down - S&P e-minis and Nasdaq 100 contracts are up 0.1%. In commodities, WTI Crude Oil is still bid above $86 per barrel. while precious metals remain supported by a bout of USD weakness - Gold is above $4,585 and Silver has advanced above $68 per ounce.Check out this evening's top movers from around Wall Street, compiled by The Fly.HIGHER AFTER EARNINGS -Ross Storesup 8.1%ALSO HIGHER -Spotify Technologyup 1.3% after boosting share buybackDOWN AFTER EARNINGS -Flux Powerdown 20.6%Flowers Foodsdown 4.2%OSI Systemsdown 3.7%ALSO LOWER -Aveanna Healthcaredown 9.3% after equity offeringNewcelX Ltd.down 5.0% after selling stock for holders
Aveanna Healthcare Launches Secondary Offering of 15 Million Shares
Aveanna Healthcare Holdings announced that certain selling stockholders, including affiliates of J.H. Whitney Equity Partners VII, and certain current and former directors and officers of the company, have commenced a secondary offering of 15M shares of its common stock. The company is not offering any shares of its common stock in the offering and will not receive any of the proceeds from the sale of the shares offered by the selling stockholders. RBC Capital Markets will serve as the sole book-running manager for the offering.
Aveanna Reports Q2 Revenue of $670.48M, Exceeds Expectations
Reports Q2 revenue $670.48M, consensus $639.63M. Jeff Shaner, Chief Executive Officer, commented, "Our second quarter results demonstrate the momentum across Aveanna and our ability to consistently deliver sustained year-over-year growth. Revenue and Adjusted EBITDA increased 13.7% and 8.0%, respectively, compared to the prior-year period, reflecting our strong organic growth across all three business segments. Our results reinforce the strength of our operating model, the continued success of our Preferred Payor and Government Affairs strategies, and the dedication of our team to deliver exceptional care to patients and families. Given our performance in the first half of the year and confidence in our outlook, we are pleased to raise our 2026 revenue and Adjusted EBITDA guidance."
Aveanna Raises FY26 Adjusted EBITDA Outlook to Over $365M
Raises FY26 adjusted EBITDA view to greater than $365M from $338M-$342M. Matt Buckhalter, Chief Financial Officer, commented "Aveanna's second quarter results continued our momentum with our team executing at a high level across all three divisions. During the quarter, we delivered revenue of $670.5 million and Adjusted EBITDA of $95.4 million. These results, combined with the acquisition of Family First and the successful repricing of our credit facility demonstrate the strength of our platform and our commitment to sustainable growth while delivering high-quality care to the patients and families we serve. Our increased 2026 guidance, including revenue of greater than $2.68 billion and Adjusted EBITDA of greater than $365 million, underscores the strength of our business model and the opportunities ahead as we continue to execute on our strategic initiatives."
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。